Author

Sylvie N’Gbeche

Observed names: N’Gbeche, Sylvie, S. N'Gbeche, S. N’gbeche, Sylvie N'Gbeche, Sylvie N'gbeche, Sylvie Ngbeché

Observed institutions: University of the Witwatersrand, Centre Hospitalier Universitaire Yalgado Ouédraogo, Société de Développement des Forêts

OpenAlex ID: A5008354880

Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe

2016 · Michael Schomaker, Valeriane Leroy, et al. · International Journal of Epidemiology · 44

Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation

2015 · Sophie Desmonde, François T. Eboua, et al. · AIDS · 23

Virological response and resistances over 12 months among HIV‐infected children less than two years receiving first‐line lopinavir/ritonavir‐based antiretroviral therapy in Cote d’Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort

2017 · Clarisse Amani‐Bosse, Désiré Lucien Dahourou, et al. · Journal of the International AIDS Society · 21

Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children aged 1-5 Years

2015 · Michael Schomaker, Mary-Ann Davies, et al. · Epidemiology · 17

Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d’Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial

2017 · on behalf of the MONOD Study Group, Désiré Lucien Dahourou, et al. · BMC Medicine · 15

Assessment of dietary diversity and nutritional support for children living with HIV in the IeDEA pediatric West African cohort: a non-comparative, feasibility study

2021 · Julie Jesson, Ayoko Ephoevi-Ga, et al. · BMC Nutrition · 6

Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children aged 1-5 Years: A Causal Modelling Analysis

2020 · N’Gbeche, Sylvie, Schomaker, Michael, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill) · 5

Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d’Ivoire

2016 · Sophie Desmonde, Divine Avit, et al. · PLoS ONE · 5

Disparities in dolutegravir utilisation in children, adolescents and young adults (0–24 years) living with HIV. An analysis of the IeDEA Pediatric West African cohort

2025 · Sophie Desmonde, Joycelyn Dame, et al. · BMJ Global Health · 3

Une transition lente vers les traitements antirétroviraux à base de Dolutégravir chez les enfants vivants avec le VIH en Afrique de l'Ouest

2023 · S. Desmonde, A. David, et al. · Revue d Épidémiologie et de Santé Publique

Coûts de la prise en charge des enfants infectés par le VIH initiant un traitement antirétroviral à base de lopinavir/ritonavir avant l’âge de 2 ans à Abidjan, Côte d’Ivoire

2016 · S. Desmonde, D. Avit-Edi, et al. · Revue d Épidémiologie et de Santé Publique

Works count: 14

Citation count: 139

H-index: 6

I10-index: 5